Other MRI vendors could be next on Fonar's list A trial date has been set for Fonar's patent infringement lawsuitagainst GE, Hitachi and two imaging centers. Depending on theoutcome of the case, other MRI vendors could be targeted withsimilar
A trial date has been set for Fonar's patent infringement lawsuitagainst GE, Hitachi and two imaging centers. Depending on theoutcome of the case, other MRI vendors could be targeted withsimilar litigation, according to an attorney representing Fonar.
Fonar filed a federal lawsuit in September of 1992 chargingthe defendants with violating four of its patents on basic MRItechnology (SCAN 9/16/92). The defendants are GE; four companiesassociated with Hitachi, including Hitachi Medical Systems America;Brookhaven Magnetic Resonance of Patchogue, NY; and South ShoreImaging of Rockville Center, NY. Fonar earlier this year addedanother patent claim to its case against Hitachi.
A trial on the claims has been set to begin this December inU.S. District Court for Eastern New York in Hauppauge, NY, Fonarannounced last month. Fonar is seeking monetary damages and aninjunction preventing the unlicensed use of its patents.
Fonar is suing for violation of the original MRI patent grantedto company founder Raymond Damadian, as well as another patentrelating to basic MR imaging and three patents relating to MRIusing permanent magnets. Fonar is suing GE and South Shore Imagingon the first two claims and Hitachi and Brookhaven on all five,according to Fonar counsel Ronald J. Schutz of Robins, Kaplan,Miller and Ciresi of Minneapolis. South Shore uses a GE system,while Brookhaven is a Hitachi customer.
The case is currently in discovery, Schutz said. In depositions,Fonar has acquired financial information about GE's MRI businessto use as a guide for determining damages if it wins the case.Fonar will not make that information public, he said.
Fonar's patents are broad enough that the company could pursuelitigation against other MRI vendors besides GE and Hitachi, Schutzsaid. Fonar has sent letters to other MRI companies notifyingthem that Fonar believes they are infringing on its patents. Fonarmay pursue litigation against these companies depending on theoutcome of the case against GE and Hitachi.
"We could sue other vendors," Schutz said. "Weare taking a wait-and-see attitude with the current case."
In other Fonar news, the Melville, NY, company reported improvedfinancial results for the third quarter (end-March). Fonar hadrevenues for the quarter of $5 million, up 5% from the $4.8 millionrecorded last year. The firm posted a gain for the quarter, withnet income of $56,000 compared to a loss of $123,000 for the sameperiod last year.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.